Nuzenio

Trevi

Trevi news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 19:09:24 GMTTrevi Therapeutics (TRVI) Starts Key Cough Trials, Is It Still 29% Below Fair Value? - Sahm
Fri, 07 Aug 2026 23:12:38 GMTTrevi Therapeutics (NASDAQ:TRVI) Announces Earnings Results, Hits Estimates - MarketBeat
Fri, 07 Aug 2026 19:57:33 GMTTREVI (BIT:TFIN) Stock Rebounds On Profit Jump As Valuation Stays Rich - simplywall.st
Fri, 07 Aug 2026 18:04:23 GMTTrevi Therapeutics Q2 Earnings Call Highlights - Yahoo Finance
Fri, 07 Aug 2026 17:20:32 GMTTrevi Therapeutics, Inc. Stock 12‑Month Price Target Raised to $29.17, Implies 58% Upside - TradingView
Fri, 07 Aug 2026 13:52:56 GMTOppenheimer Adjusts Trevi Therapeutics PT to $25 From $24, Maintains Outperform Rating - marketscreener.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Trevi.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.